NOTV Inotiv, Inc.

Nasdaq inotivco.com


$ 1.42 $ 0.02 (1.42 %)    

Wednesday, 15-Oct-2025 15:59:53 EDT
QQQ $ 605.77 $ 0.00 (0 %)
DIA $ 463.67 $ 0.00 (0 %)
SPY $ 667.74 $ 0.00 (0 %)
TLT $ 90.71 $ 0.00 (0 %)
GLD $ 390.27 $ 0.00 (0 %)
$ 1.43
$ 1.43
$ 1.43 x 2,000
$ 1.45 x 4
-- - --
$ 1.15 - $ 6.48
250,343
na
36.65M
$ 2.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-06-2025 12-31-2024 10-Q
4 12-04-2024 09-30-2024 10-K
5 08-08-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 02-07-2024 12-31-2023 10-Q
8 12-12-2023 09-30-2023 10-K
9 08-11-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 02-14-2023 12-31-2022 10-Q
12 01-13-2023 09-30-2022 10-K
13 08-12-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 02-16-2022 12-31-2021 10-Q
16 12-21-2021 09-30-2021 10-K
17 08-13-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 02-10-2021 12-31-2020 10-Q
20 12-22-2020 09-30-2020 10-K
21 08-14-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 02-14-2020 12-31-2019 10-Q
24 12-26-2019 09-30-2019 10-K
25 08-14-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 02-14-2019 12-31-2018 10-Q
28 12-21-2018 09-30-2018 10-K
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 02-14-2018 12-31-2017 10-Q
32 12-22-2017 09-30-2017 10-K
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 02-14-2017 12-31-2016 10-Q
36 12-28-2016 09-30-2016 10-K
37 08-15-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 02-16-2016 12-31-2015 10-Q
40 12-24-2015 09-30-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 inotiv-says-timeline-for-completion-of-restoration-efforts-related-to-cybersecurity-incident-is-not-yet-known-not-yet-determined-if-2025-cybersecurity-incident-is-likely-to-have-material-impact

https://www.sec.gov/ix?doc=/Archives/edgar/data/0000720154/000162828025042837/notv-20250821.htm

 inotiv-enters-settlement-agreement-for-securities-class-action-2025-cybersecurity-incident-is-expected-to-continue-to-cause-disruptions-to-certain-business-operations-of-co-to-pay-875m-cash-settlement

https://www.sec.gov/ix?doc=/Archives/edgar/data/0000720154/000162828025042837/notv-20250821.htm

 inotiv-files-for-mixed-shelf-offering-of-up-to-3500m

-SEC Filing

 inotiv-q3-eps-051-beats-052-estimate-sales-130683m-beat-127052m-estimate

Inotiv (NASDAQ:NOTV) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.52) by 0.9...

 sec-division-of-enforcement-ends-probe-recommends-no-action-against-inotiv

As previously disclosed, on May 23, 2023, Inotiv, Inc. (the "Company") received a voluntary request from the U.S. Secur...

 lake-street-maintains-buy-on-inotiv-lowers-price-target-to-5

Lake Street analyst Frank Takkinen maintains Inotiv (NASDAQ:NOTV) with a Buy and lowers the price target from $6 to $5.

 nvidia-backed-recursion-ginkgo-bioworks-rally-following-fdas-decision-to-end-animal-testing

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

 inotiv-q1-eps-102-beats-103-estimate-sales-11988m-miss-12183m-estimate

Inotiv (NASDAQ:NOTV) reported quarterly losses of $(1.02) per share which beat the analyst consensus estimate of $(1.03) by 0.9...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION